ATE435225T1 - Oxadiazolonderivate als ppar-delta-agonisten - Google Patents
Oxadiazolonderivate als ppar-delta-agonistenInfo
- Publication number
- ATE435225T1 ATE435225T1 AT05716233T AT05716233T ATE435225T1 AT E435225 T1 ATE435225 T1 AT E435225T1 AT 05716233 T AT05716233 T AT 05716233T AT 05716233 T AT05716233 T AT 05716233T AT E435225 T1 ATE435225 T1 AT E435225T1
- Authority
- AT
- Austria
- Prior art keywords
- ppar
- delta agonists
- oxadiazolone derivatives
- oxadiazolone
- derivatives
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- ZVTQYRVARPYRRE-UHFFFAOYSA-N oxadiazol-4-one Chemical class O=C1CON=N1 ZVTQYRVARPYRRE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04007879A EP1586573B1 (de) | 2004-04-01 | 2004-04-01 | Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika |
| PCT/EP2005/002950 WO2005097786A1 (en) | 2004-04-01 | 2005-03-19 | Oxadiazolone derivatives as ppar delta agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435225T1 true ATE435225T1 (de) | 2009-07-15 |
Family
ID=34924545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05716233T ATE435225T1 (de) | 2004-04-01 | 2005-03-19 | Oxadiazolonderivate als ppar-delta-agonisten |
Country Status (37)
| Country | Link |
|---|---|
| US (3) | US20070179191A1 (de) |
| EP (3) | EP1586573B1 (de) |
| JP (1) | JP2007530612A (de) |
| KR (1) | KR20060135857A (de) |
| CN (1) | CN100582104C (de) |
| AR (1) | AR050576A1 (de) |
| AT (1) | ATE435225T1 (de) |
| AU (1) | AU2005231916A1 (de) |
| BR (1) | BRPI0509517A (de) |
| CA (1) | CA2561627A1 (de) |
| CR (1) | CR8572A (de) |
| CY (1) | CY1109370T1 (de) |
| DE (2) | DE602004004631D1 (de) |
| DK (1) | DK1740583T3 (de) |
| DO (1) | DOP2005000051A (de) |
| EC (1) | ECSP066892A (de) |
| ES (1) | ES2329484T3 (de) |
| GT (1) | GT200500028A (de) |
| HR (1) | HRP20090493T1 (de) |
| IL (1) | IL178056A0 (de) |
| MA (1) | MA28495B1 (de) |
| MY (1) | MY142431A (de) |
| NO (1) | NO20064981L (de) |
| PA (1) | PA8628701A1 (de) |
| PE (1) | PE20060323A1 (de) |
| PL (1) | PL1740583T3 (de) |
| PT (1) | PT1740583E (de) |
| RS (1) | RS51186B (de) |
| RU (1) | RU2374243C2 (de) |
| SI (1) | SI1740583T1 (de) |
| SV (1) | SV2006002071A (de) |
| TN (1) | TNSN06317A1 (de) |
| TW (1) | TW200602342A (de) |
| UA (1) | UA84203C2 (de) |
| UY (1) | UY28837A1 (de) |
| WO (1) | WO2005097786A1 (de) |
| ZA (1) | ZA200606870B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060017929A (ko) * | 2004-08-04 | 2006-02-28 | 동화약품공업주식회사 | 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물 |
| JP2009509988A (ja) | 2005-09-29 | 2009-03-12 | サノフィ−アベンティス | フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用 |
| WO2007039176A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Derivatives of 2 -aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals |
| CA2624093A1 (en) * | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridyl-i,2,4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| CA2663121C (en) | 2006-09-08 | 2016-01-19 | Rhode Island Hospital | Treatment, prevention, and reversal of alcohol-induced brain disease |
| EP2061484B1 (de) | 2006-09-08 | 2012-11-07 | Rhode Island Hospital | Behandlung, vorbeugung und umkehrung alkohol-induzierter lebererkrankungen |
| EP1932843A1 (de) * | 2006-12-14 | 2008-06-18 | sanofi-aventis | Sulfonyl-Phenyl-2H-(1,2,4) Oxadiazol-5-one-Derivate, Verfahren zur Herstellung dafür und zur pharmazeutischen Verwendung damit |
| WO2010000353A1 (en) * | 2008-06-09 | 2010-01-07 | Sanofi-Aventis | Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| EP2288605B1 (de) * | 2008-06-09 | 2014-06-25 | Sanofi | Annelierte pyrrolidinsulfonamide mit einer oxadiazolon-kopfgruppe, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika |
| RU2010154279A (ru) | 2008-06-09 | 2012-07-20 | Санофи-Авентис (Fr) | Аннелированные n-гетероциклические сульфонамиды с оксадиазолоновой концевой группой, способы их получения и их применение в качестве фармацевтических препаратов |
| CN106243100B (zh) | 2008-10-10 | 2019-04-09 | Vm生物医药公司 | 治疗酒精使用障碍，疼痛和其他疾病的药物组合与方法 |
| ES2567455T3 (es) | 2008-10-10 | 2016-04-22 | Dara Biosciences, Inc. | Nanoemulsiones que comprenden derivados de espicamicina para su uso en el tratamiento del dolor |
| NZ597895A (en) * | 2009-08-05 | 2012-11-30 | Daiichi Sankyo Co Ltd | Amide derivative |
| US8754112B2 (en) * | 2009-08-05 | 2014-06-17 | Daiichi Sankyo Company, Limited | Sulfone derivative |
| WO2015061481A1 (en) | 2013-10-23 | 2015-04-30 | Dara Biosciences, Inc. | Methods of treating liquid tumors using compositions comprising spicamycin derivatives |
| US20220387393A1 (en) * | 2019-11-06 | 2022-12-08 | Board Of Regents, The University Of Texas System | Methods for the treatment of dysmyelinating/demyelinating diseases |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256680A (en) | 1988-11-29 | 1993-10-26 | Warner-Lambert Company | 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents |
| FR2663336B1 (fr) | 1990-06-18 | 1992-09-04 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| TW222626B (de) * | 1991-07-22 | 1994-04-21 | Pfizer | |
| IL108633A (en) | 1993-02-15 | 1998-07-15 | Wellcome Found | History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them |
| IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
| US5641796A (en) * | 1994-11-01 | 1997-06-24 | Eli Lilly And Company | Oral hypoglycemic agents |
| JP3144624B2 (ja) | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| CN1158290C (zh) | 1996-01-17 | 2004-07-21 | 诺沃挪第克公司 | 稠合1,2,4-噻二嗪与稠合1,4-噻嗪衍生物、其制备方法及用途 |
| CZ300837B6 (cs) | 1996-08-30 | 2009-08-26 | Novo Nordisk A/S | Deriváty GLP-1(7-37) nebo jeho analogy, farmaceutický prostredek je obsahující a jejich použití |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| JP4339402B2 (ja) | 1996-12-31 | 2009-10-07 | ドクター・レディーズ・ラボラトリーズ・リミテッド | 新規なヘテロ環化合物、これらの製造方法及びこれらを含有する薬学的組成物、並びに糖尿病及び関連疾患の治療におけるこれらの使用 |
| DE19726167B4 (de) | 1997-06-20 | 2008-01-24 | Sanofi-Aventis Deutschland Gmbh | Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung |
| IL133604A0 (en) | 1997-07-16 | 2001-04-30 | Novo Nordisk As | Fused 1, 2, 4-thiadiazine derivatives, their preparation and use |
| CO4970713A1 (es) | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
| DE19823831A1 (de) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| MA26634A1 (fr) | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| SE9801992D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| US6221897B1 (en) | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| DE19828114A1 (de) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
| DE19828113A1 (de) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
| DE19845405C2 (de) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
| DE19916108C1 (de) | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
| EP1173438A1 (de) | 1999-04-16 | 2002-01-23 | Novo Nordisk A/S | Substituierte imidazole, ihre herstellung und ihre verwendung |
| EE200100556A (et) | 1999-04-28 | 2003-02-17 | Aventis Pharma Deutschland Gmbh | Diarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi kasutamine ravimite valmistamiseks |
| EE200100558A (et) | 1999-04-28 | 2002-12-16 | Aventis Pharma Deutschland Gmbh | Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine |
| WO2000066585A1 (en) | 1999-04-30 | 2000-11-09 | Neurogen Corporation | 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS |
| GB9911863D0 (en) | 1999-05-21 | 1999-07-21 | Knoll Ag | Therapeutic agents |
| DE60029446T2 (de) | 1999-06-18 | 2007-02-08 | Merck & Co., Inc. | Arylthiazolidindione und aryloxazolidindion-derivate |
| GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| AU5784000A (en) | 1999-07-09 | 2001-01-30 | Cohesion Technologies, Inc. | Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
| JP2003506365A (ja) | 1999-07-29 | 2003-02-18 | イーライ・リリー・アンド・カンパニー | ベンゾフリルピペラジンおよびベンゾフリルホモピペラジン：セロトニンアゴニスト |
| WO2001016094A1 (de) | 1999-09-01 | 2001-03-08 | Aventis Pharma Deutschland Gmbh | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| TW200514783A (en) | 1999-09-22 | 2005-05-01 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method |
| SE9904413D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | Comminuted form |
| AU773777B2 (en) | 1999-12-03 | 2004-06-03 | Astrazeneca Ab | Crystalline form of (S)-2 ethoxy-3-(4-(2-(4-methanesulfonyloxyphenyl) ethoxy) phenyl) propanoic acid |
| DE60137216D1 (de) | 2000-03-31 | 2009-02-12 | Prosidion Ltd | Verbesserung der aktivität der inselzellen bei diabetes mellitus und dessen prävention |
| WO2001081327A1 (en) | 2000-04-25 | 2001-11-01 | Kyorin Pharmaceutical Co., Ltd. | Novel stable crystal of thiazolidinedione derivative and process for producing the same |
| ATE369337T1 (de) | 2000-04-28 | 2007-08-15 | Asahi Kasei Pharma Corp | Neue bizyklische verbindungen |
| CN1244561C (zh) | 2000-05-11 | 2006-03-08 | 布里斯托尔-迈尔斯斯奎布公司 | 可用作生长激素促分泌素的四氢异喹啉类似物 |
| AU6497701A (en) | 2000-05-30 | 2001-12-11 | Merck & Co Inc | Melanocortin receptor agonists |
| AU2001262318B2 (en) | 2000-06-09 | 2005-09-08 | Sanofi-Aventis Deutschland Gmbh | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
| HRP20030498A2 (en) | 2000-12-21 | 2005-04-30 | Aventis Pharma Deutschland Gmbh | Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| EP1368011A1 (de) | 2001-02-22 | 2003-12-10 | SmithKline Beecham Corporation | Methode zur behandlung ppar gamma bedingter erkrankungen |
| DE10112768A1 (de) | 2001-03-16 | 2002-09-19 | Merck Patent Gmbh | Phenylderivate 3 |
| GB0111523D0 (en) | 2001-05-11 | 2001-07-04 | Glaxo Group Ltd | Chemical compounds |
| PE20021091A1 (es) | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| DE10154689A1 (de) | 2001-11-09 | 2003-05-22 | Probiodrug Ag | Substituierte Aminoketonverbindungen |
| UA76773C2 (uk) | 2001-08-31 | 2006-09-15 | Санофі-Авентіс Дойчланд Гмбх | Діарилциклоалкільні похідні, спосіб їх одержання і їх застосування як ppar-активаторів |
| US7205321B2 (en) * | 2001-11-15 | 2007-04-17 | Eli Lilly And Company | Peroxisome proliferator activated receptor alpha agonists |
| IL164249A0 (en) | 2002-04-11 | 2005-12-18 | Aventis Pharma Gmbh | Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use |
| DE10215908B4 (de) | 2002-04-11 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel |
| DE10225635C1 (de) | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
| WO2004094394A1 (en) | 2003-04-01 | 2004-11-04 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
| US7217727B2 (en) | 2003-04-01 | 2007-05-15 | Eli Lilly And Company | Phospholipase inhibitors |
| DE102004005172A1 (de) | 2004-02-02 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase |
| CA2624093A1 (en) * | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridyl-i,2,4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
-
2004
- 2004-04-01 DE DE602004004631T patent/DE602004004631D1/de not_active Expired - Lifetime
- 2004-04-01 EP EP04007879A patent/EP1586573B1/de not_active Expired - Lifetime
-
2005
- 2005-02-17 GT GT200500028A patent/GT200500028A/es unknown
- 2005-03-19 JP JP2007505433A patent/JP2007530612A/ja not_active Abandoned
- 2005-03-19 UA UAA200611486A patent/UA84203C2/ru unknown
- 2005-03-19 SI SI200530778T patent/SI1740583T1/sl unknown
- 2005-03-19 AT AT05716233T patent/ATE435225T1/de not_active IP Right Cessation
- 2005-03-19 RS RSP-2009/0391A patent/RS51186B/sr unknown
- 2005-03-19 KR KR1020067020503A patent/KR20060135857A/ko not_active Ceased
- 2005-03-19 PT PT05716233T patent/PT1740583E/pt unknown
- 2005-03-19 DE DE602005015204T patent/DE602005015204D1/de not_active Expired - Lifetime
- 2005-03-19 CN CN200580010743A patent/CN100582104C/zh not_active Expired - Fee Related
- 2005-03-19 RU RU2006138498/04A patent/RU2374243C2/ru not_active IP Right Cessation
- 2005-03-19 HR HR20090493T patent/HRP20090493T1/xx unknown
- 2005-03-19 EP EP05716233A patent/EP1740583B1/de not_active Expired - Lifetime
- 2005-03-19 BR BRPI0509517-4A patent/BRPI0509517A/pt not_active IP Right Cessation
- 2005-03-19 AU AU2005231916A patent/AU2005231916A1/en not_active Abandoned
- 2005-03-19 WO PCT/EP2005/002950 patent/WO2005097786A1/en not_active Ceased
- 2005-03-19 EP EP09005458A patent/EP2083006A1/de not_active Withdrawn
- 2005-03-19 DK DK05716233T patent/DK1740583T3/da active
- 2005-03-19 ES ES05716233T patent/ES2329484T3/es not_active Expired - Lifetime
- 2005-03-19 CA CA002561627A patent/CA2561627A1/en not_active Abandoned
- 2005-03-19 PL PL05716233T patent/PL1740583T3/pl unknown
- 2005-03-22 PE PE2005000323A patent/PE20060323A1/es not_active Application Discontinuation
- 2005-03-30 TW TW094109908A patent/TW200602342A/zh unknown
- 2005-03-30 AR ARP050101221A patent/AR050576A1/es not_active Application Discontinuation
- 2005-03-30 DO DO2005000051A patent/DOP2005000051A/es unknown
- 2005-03-31 MY MYPI20051461A patent/MY142431A/en unknown
- 2005-04-01 PA PA20058628701A patent/PA8628701A1/es unknown
- 2005-04-01 UY UY28837A patent/UY28837A1/es unknown
- 2005-04-01 SV SV2005002071A patent/SV2006002071A/es not_active Application Discontinuation
-
2006
- 2006-08-15 ZA ZA200606870A patent/ZA200606870B/en unknown
- 2006-08-24 CR CR8572A patent/CR8572A/es not_active Application Discontinuation
- 2006-09-13 IL IL178056A patent/IL178056A0/en unknown
- 2006-09-26 US US11/535,266 patent/US20070179191A1/en not_active Abandoned
- 2006-09-29 TN TNP2006000317A patent/TNSN06317A1/en unknown
- 2006-09-29 MA MA29354A patent/MA28495B1/fr unknown
- 2006-09-29 EC EC2006006892A patent/ECSP066892A/es unknown
- 2006-10-31 NO NO20064981A patent/NO20064981L/no not_active Application Discontinuation
-
2008
- 2008-06-05 US US12/133,408 patent/US20080262052A1/en not_active Abandoned
- 2008-06-05 US US12/133,405 patent/US7709509B2/en not_active Expired - Fee Related
-
2009
- 2009-09-16 CY CY20091100958T patent/CY1109370T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE504559T1 (de) | Arylanilinderivate als agonisten des beta2- adrenergen rezeptors | |
| DE602006015607D1 (de) | Thiazol-4-carboxamid-derivate als mglur5-antagonisten | |
| ATE487719T1 (de) | Xanthinderivate als selektive hm74a-agonisten | |
| ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
| ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
| DE602006007563D1 (de) | Agonisten | |
| ATE420088T1 (de) | Chinolinoncarbonsäureamidverbindungen als 5-ht4- rezeptoragonisten | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| ATE486874T1 (de) | Purinonderivate als hm74a-agonisten | |
| ATE479676T1 (de) | Als antikoagulanzien verwendbare phenylglycinamid-derivate | |
| ATE537149T1 (de) | Sulfonyl-pyrazolinyl-1-carboxamidinderivate als 5-ht6-antagonisten | |
| DE602004025215D1 (de) | Tastsonde | |
| ATE549350T1 (de) | Neuropeptid-2-rezeptor-agonisten | |
| DE602006003628D1 (de) | Purinderivate als a2a-rezeptoragonisten | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| ATE435225T1 (de) | Oxadiazolonderivate als ppar-delta-agonisten | |
| DE602006019624D1 (de) | Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors | |
| DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
| ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
| DK1971588T3 (da) | Tiglien-3-onderivater | |
| ATE535523T1 (de) | Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten | |
| DE502005000300D1 (de) | Tastkopf | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1740583 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1740583 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |